Legend Biotech Corp (LEGN) stock forecast and price target
Price $17.50 · data as of November 13, 2026
12-month price target
Average target$42.54
Upside / downside+143.1%
Analysts13
ConsensusBuy
Low $21.00Average $42.54High $65.00
Gold marker: average target · white marker: today’s price ($17.50)
Analyst ratings
Strong buy 5Buy 3Hold 5Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $0.12 | +107.8% | $1.4B |
| Next fiscal year ends December 31, 2027 | $0.54 | +323.6% | $1.7B |
| Next quarter ends December 31, 2026 | $0.07 | +140.6% | $360M |
| Quarter after ends December 31, 2026 | $0.15 | +193.8% | $402M |
Consensus of the analysts covering Legend Biotech, updated daily.
Frequently asked questions
What is the Legend Biotech stock price target?
The average 12-month target from 13 analysts is $42.54, 143.1% above the current price of $17.50 Targets range from $21.00 to $65.00.
Is Legend Biotech a buy according to analysts?
The consensus rating is “Buy” (5 strong buy, 3 buy, 5 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Legend Biotech expected to earn?
Analysts expect EPS of $0.12 for the fiscal year ending December 31, 2026 and $0.54 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.